In the wake of new immunotherapies being approved by the FDA and many more in clinical trials, will transplants continue to be an integral part of myeloma treatment? With therapeutic potential of a myeloma cure, the use of donor stem cell transplantation/ allogeneic transplantation is highly debated in the medical field due to associated risks; when does benefits outweigh the risks and can allo transplants be used to salvage and cure relapsed patients? What about curative potential of autologous transplants? With modern therapies storming the myeloma armamentarium, Dr. Frits van Rhee of UAMS is back on CureTalks discussing auto transplants for treatment of myeloma and giving his take on allogeneic transplants is Dr. Gosta Gahrton of Karolinska Institute (Has been member and chairman of Nobel Committee of the Karolinska Institute). Myeloma panel includes advocates and survivors, Gary Petersen, Jack Aiello, and Nick van Dyk.
Sorry we couldn't complete your registration. Please try again.
You must accept the Terms and conditions to register